Mrv1909 12052217152D 20 20 0 0 0 0 999 V2000 1.8529 -8.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5674 -8.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2818 -8.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9963 -8.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7108 -8.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4253 -8.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.1397 -8.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.8542 -8.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.5687 -8.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.2831 -8.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.9976 -8.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7121 -8.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4266 -8.5585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 11.1082 -8.0937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.8965 -8.3369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.1980 -9.1049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.7855 -9.8194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.9697 -9.9423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.3649 -9.3812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.5969 -9.6826 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 18 19 1 0 0 0 0 13 19 1 0 0 0 0 19 20 2 0 0 0 0 M END > DB17308 > drugbank > CCCCCCCCCCCCN1CCCCCC1=O > InChI=1S/C18H35NO/c1-2-3-4-5-6-7-8-9-10-13-16-19-17-14-11-12-15-18(19)20/h2-17H2,1H3 > AXTGDCSMTYGJND-UHFFFAOYSA-N > C18H35NO > 281.484 > 281.271864751 > 1 > 55 > 1.3010686606227278e-08 > 37.25802867321657 > 0 > 0 > 0 > 1 > 1-dodecylazepan-2-one > 5.32 > 5.413652432 > -5.73 > 0 > 0 > 1 > 0 > -0.8856997783853683 > 20.310000000000002 > 87.03819999999999 > 11 > 0 > 5.26e-04 g/l > laurocapram > 0 > DB17308 > approved > Laurocapram > 1-dodecylazacycloheptan-2-one; 1-dodecylhexahydro-2h-azepin-2-one; 1-n-dodecylazacycloheptan-2-one; 2h-azepin-2-one, 1-dodecylhexahydro-; Azone; N-dodecyl-.epsilon.-caprolactam > Fatazen Sweat Enhance Hot $$$$